Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 42,157 followers.

RT @FrontImmunol: New Research: Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review…

20 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review…

20 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review…

20 Feb 2024

Reply Repost Favourite

New Research: Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review: Background Neoadjuvant immunotherapy has demonstrated beneficial outcomes in various cancer types; however,… https://t.co/r24ZMbFxmG

20 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.